Detalhe da pesquisa
1.
Comprehensive Prognostication in Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results from Merging the Center for International Blood and Marrow Transplant Research (CIBMTR) and Virtual Pediatric Systems (VPS) Registries.
Biol Blood Marrow Transplant
; 26(2): 333-342, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31563573
2.
Taurine alleviates repression of betaine-homocysteine S-methyltransferase and significantly improves the efficacy of long-term betaine treatment in a mouse model of cystathionine ß-synthase-deficient homocystinuria.
FASEB J
; 33(5): 6339-6353, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30768359
3.
Glycemic variability is associated with poor outcomes in pediatric hematopoietic stem cell transplant patients.
Pediatr Blood Cancer
; 67(11): e28626, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33480469
4.
Eliminating disparities improves outcomes.
Blood
; 137(4): 439-441, 2021 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33507300
5.
Out-of-specification tisagenlecleucel does not compromise safety or efficacy in pediatric acute lymphoblastic leukemia.
Blood
; 138(21): 2138-2142, 2021 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34499715
6.
Hematopoietic Stem Cell Transplantation Activity in Pediatric Cancer between 2008 and 2014 in the United States: A Center for International Blood and Marrow Transplant Research Report.
Biol Blood Marrow Transplant
; 23(8): 1342-1349, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28450183
7.
Mer receptor tyrosine kinase is a therapeutic target in pre-B-cell acute lymphoblastic leukemia.
Blood
; 122(9): 1599-609, 2013 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-23861246
8.
Effects of total body irradiation on hematopoietic cell transplantation outcomes in pediatric acute myeloid leukemia with prior central nervous system involvement.
Transplant Cell Ther
; 2024 May 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38763417
9.
Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment.
Nat Commun
; 15(1): 3258, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38637498
10.
Late effects of total body irradiation and hematopoietic stem cell transplant in children under 3 years of age.
Pediatr Blood Cancer
; 60(4): 700-4, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22848000
11.
Access to Chimeric Antigen Receptor T Cell Clinical Trials in Underrepresented Populations: A Multicenter Cohort Study of Pediatric and Young Adult Acute Lymphobastic Leukemia Patients.
Transplant Cell Ther
; 29(6): 356.e1-356.e7, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36966871
12.
Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials.
Transplant Cell Ther
; 29(5): 338.e1-338.e6, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36775201
13.
Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia.
J Clin Oncol
; 41(2): 354-363, 2023 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36108252
14.
HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL.
Blood Adv
; 7(12): 2758-2771, 2023 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36857419
15.
Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium.
Blood Adv
; 7(4): 541-548, 2023 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35938863
16.
Pulmonary microbiome and transcriptome signatures reveal distinct pathobiologic states associated with mortality in two cohorts of pediatric stem cell transplant patients.
medRxiv
; 2023 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38077035
17.
Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy.
Blood Adv
; 6(7): 1961-1968, 2022 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34788386
18.
Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report.
Blood Adv
; 6(2): 600-610, 2022 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34794180
19.
Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report.
J Clin Oncol
; 40(9): 945-955, 2022 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34882493
20.
Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia.
Blood Adv
; 6(14): 4251-4255, 2022 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35580324